338 related articles for article (PubMed ID: 7581147)
61. Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials.
Michael M; Elliott EJ; Craig JC; Ridley G; Hodson EM
Am J Kidney Dis; 2009 Feb; 53(2):259-72. PubMed ID: 18950913
[TBL] [Abstract][Full Text] [Related]
62. [Thrombotic microangiopathy (DIC,TTP and HUS)--recent advances in pathogenesis and management].
Saito H
Nihon Rinsho; 1993 Jan; 51(1):5-10. PubMed ID: 8433528
[No Abstract] [Full Text] [Related]
63. Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation.
Teruya J; Styler M; Verde S; Topolsky D; Crilley P
J Clin Apher; 2001; 16(4):169-74. PubMed ID: 11835412
[TBL] [Abstract][Full Text] [Related]
64. [Therapeutic plasma exchange in the treatment of the hereditary thrombotic thrombocytopenic purpura].
Cermáková Z; Korístka M; Korístková B; Hrdlicková R; Suláková T; Furková J; Kovárová P
Cas Lek Cesk; 2009; 148(10):493-6. PubMed ID: 20662412
[TBL] [Abstract][Full Text] [Related]
65. Management of Thrombotic Microangiopathic Hemolytic Anemias with Therapeutic Plasma Exchange: When It Works and When It Does Not.
Mehmood T; Taylor M; Winters JL
Hematol Oncol Clin North Am; 2016 Jun; 30(3):679-94. PubMed ID: 27113004
[TBL] [Abstract][Full Text] [Related]
66. A case of thrombotic thrombocytopenic purpura following allogeneic bone marrow transplantation.
Tschuchnigg M; Bradstock KF; Koutts J; Stewart J; Enno A; Seldon M
Bone Marrow Transplant; 1990 Jan; 5(1):61-3. PubMed ID: 2297591
[TBL] [Abstract][Full Text] [Related]
67. Successful treatment of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura with fresh frozen plasma and plasma exchange.
Thysell H; Oxelius VA; Norlin M
Acta Med Scand; 1982; 212(5):285-8. PubMed ID: 6891171
[TBL] [Abstract][Full Text] [Related]
68. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura: outcome with plasma exchange.
Roberts AW; Gillett EA; Fleming SJ
J Clin Apher; 1991; 6(3):150-4. PubMed ID: 1787131
[TBL] [Abstract][Full Text] [Related]
69. Extracorporeal treatment of thrombotic microangiopathy: a ten year experience.
Bueno D; Sevigny J; Kaplan AA
Ther Apher; 1999 Nov; 3(4):294-7. PubMed ID: 10608720
[TBL] [Abstract][Full Text] [Related]
70. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
George JN
Blood; 2000 Aug; 96(4):1223-9. PubMed ID: 10942361
[TBL] [Abstract][Full Text] [Related]
71. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and management.
George JN; Gilcher RO; Smith JW; Chandler L; Duvall D; Ellis C
J Clin Apher; 1998; 13(3):120-5. PubMed ID: 9828022
[TBL] [Abstract][Full Text] [Related]
72. [Plasma exchange therapy in patients with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome].
Ikeda Y; Kikuchi M
Nihon Rinsho; 1992 Jan; 50 Suppl():293-7. PubMed ID: 1578694
[No Abstract] [Full Text] [Related]
73. Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014.
McClain RS; Terrell DR; Vesely SK; George JN
Transfusion; 2014 Dec; 54(12):3257-9. PubMed ID: 25496391
[No Abstract] [Full Text] [Related]
74. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) following treatment with deoxycoformycin in a patient with cutaneous T-cell lymphoma (Sezary syndrome): A case report.
Leach JW; Pham T; Diamandidis D; George JN
Am J Hematol; 1999 Aug; 61(4):268-70. PubMed ID: 10440915
[TBL] [Abstract][Full Text] [Related]
75. Predictors of complications in therapeutic plasma exchange.
Bramlage CP; Schröder K; Bramlage P; Ahrens K; Zapf A; Müller GA; Koziolek MJ
J Clin Apher; 2009; 24(6):225-31. PubMed ID: 19890911
[TBL] [Abstract][Full Text] [Related]
76. Pathological and therapeutic distinctions in HUS/TTP.
Laurence J
Lancet; 2000 Feb; 355(9202):497; author reply 497-8. PubMed ID: 10841154
[No Abstract] [Full Text] [Related]
77. Pathological and therapeutic distinctions in HUS/TTP.
Fakhouri F; Vincent F; Legendre C
Lancet; 2000 Feb; 355(9202):497; author reply 497-8. PubMed ID: 10841155
[No Abstract] [Full Text] [Related]
78. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases.
Dervenoulas J; Tsirigotis P; Bollas G; Pappa V; Xiros N; Economopoulos T; Pappa M; Mellou S; Kostourou A; Papageorgiou E; Raptis SA
Ann Hematol; 2000 Feb; 79(2):66-72. PubMed ID: 10741917
[TBL] [Abstract][Full Text] [Related]
79. Advances in the treatment of TTP.
Taft EG
Prog Clin Biol Res; 1990; 337():151-5. PubMed ID: 2191309
[No Abstract] [Full Text] [Related]
80. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes.
Kojouri K; Vesely SK; George JN
Ann Intern Med; 2001 Dec; 135(12):1047-51. PubMed ID: 11747383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
